Riley C - Search Results

1

Cross A, Riley C. Cross A, et al. Among authors: riley c. Continuum (Minneap Minn). 2022 Aug 1;28(4):1025-1051. doi: 10.1212/CON.0000000000001170. Continuum (Minneap Minn). 2022. PMID: 35938656 Review.

2

Randomized study combining interferon and glatiramer acetate in multiple sclerosis.

Lublin FD, Cofield SS, Cutter GR, Conwit R, Narayana PA, Nelson F, Salter AR, Gustafson T, Wolinsky JS; CombiRx Investigators. Lublin FD, et al. Ann Neurol. 2013 Mar;73(3):327-40. doi: 10.1002/ana.23863. Epub 2013 Mar 11. Ann Neurol. 2013. PMID: 23424159 Free PMC article. Clinical Trial.

3

Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.

Govindarajan KA, Datta S, Hasan KM, Choi S, Rahbar MH, Cofield SS, Cutter GR, Lublin FD, Wolinsky JS, Narayana PA; MRI Analysis Center at Houston; CombiRx Investigators Group. Govindarajan KA, et al. Hum Brain Mapp. 2015 Oct;36(10):3749-3760. doi: 10.1002/hbm.22875. Epub 2015 Jun 19. Hum Brain Mapp. 2015. PMID: 26096844 Free PMC article. Clinical Trial.

4

Associations of social network structure with cognition and amygdala volume in multiple sclerosis: An exploratory investigation.

Kever A, Buyukturkoglu K, Levin SN, Riley CS, De Jager P, Leavitt VM. Kever A, et al. Mult Scler. 2022 Feb;28(2):228-236. doi: 10.1177/13524585211018349. Epub 2021 May 26. Mult Scler. 2022. PMID: 34037495

5

Cognitive phenotypes in multiple sclerosis.

Leavitt VM, Tosto G, Riley CS. Leavitt VM, et al. J Neurol. 2018 Mar;265(3):562-566. doi: 10.1007/s00415-018-8747-5. Epub 2018 Jan 22. J Neurol. 2018. PMID: 29356970

6

Detection of subtle gait disturbance and future fall risk in early multiple sclerosis.

Brandstadter R, Ayeni O, Krieger SC, Harel NY, Escalon MX, Katz Sand I, Leavitt VM, Fabian MT, Buyukturkoglu K, Klineova S, Riley CS, Lublin FD, Miller AE, Sumowski JF. Brandstadter R, et al. Among authors: riley cs. Neurology. 2020 Mar 31;94(13):e1395-e1406. doi: 10.1212/WNL.0000000000008938. Epub 2020 Feb 26. Neurology. 2020. PMID: 32102980 Free PMC article.

7

Switching from natalizumab to ocrelizumab in patients with multiple sclerosis.

Levin SN, Ezuma C, Levine L, Vargas WS, Farber RS, De Jager PL, Riley CS. Levin SN, et al. Among authors: riley cs. Mult Scler. 2020 Dec;26(14):1964-1965. doi: 10.1177/1352458520927631. Epub 2020 Jun 19. Mult Scler. 2020. PMID: 32552363 No abstract available.

8

ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis.

Kever A, Nelson KE, Aguerre IM, Riley CS, Boehme A, Lee NW, Strauss Farber R, Levin SN, Stein J, Leavitt VM. Kever A, et al. BMJ Open. 2020 Nov 14;10(11):e039691. doi: 10.1136/bmjopen-2020-039691. BMJ Open. 2020. PMID: 33191260 Free PMC article. Clinical Trial.

9

Social support is linked to mental health, quality of life, and motor function in multiple sclerosis.

Kever A, Buyukturkoglu K, Riley CS, De Jager PL, Leavitt VM. Kever A, et al. J Neurol. 2021 May;268(5):1827-1836. doi: 10.1007/s00415-020-10330-7. Epub 2021 Jan 3. J Neurol. 2021. PMID: 33392637

10

Evaluation of ocrelizumab in older progressive multiple sclerosis patients.

Epstein S, Fong KT, De Jager PL, Levine L, Riley C, Wesley S, Vargas WS, Farber R. Epstein S, et al. Among authors: riley c. Mult Scler Relat Disord. 2021 Oct;55:103171. doi: 10.1016/j.msard.2021.103171. Epub 2021 Jul 25. Mult Scler Relat Disord. 2021. PMID: 34329872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,054 results

Search Page